Congressman Leonard Lance (NJ 07) today announced passage of legislation to help ensure the safety of compounded drugs and our Nation's pharmaceutical supply chain. The bipartisan Drug Quality and Security Act passed the House of Representatives by a voice vote.
"This legislation, the Drug Quality and Security Act, reflects a bipartisan, bicameral effort to improve drug safety and help prevent a future public health crisis like the 2012 meningitis outbreak tied to the New England Compounding Center," said Lance, a member of the House Energy and Commerce Committee that crafted the legislation and investigated the 2012 meningitis outbreak.
The legislation would protect traditional pharmacies and clarify drug compounding laws to work to eliminate counterfeit drugs. The legislation also creates a uniform standard for security and measures to anticipate and reverse drug shortages.
"This measure will improve security and provide quality assurance in a vital area of patient care," Lance concluded.
The legislation now moves to the United States Senate where it is expected to received bipartisan support.